Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Institute for Systems Biology is currently navigating 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 4 distinct examiners and 4 distinct art units, showing a distributed prosecution profile.
The busiest examiner, EDWARD B WINSTON III, is responsible for 1 pending office action. This distribution means that each of the pending office actions is being handled by a different examiner, requiring the institute to manage separate technical dialogues simultaneously.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (25%) |
| §101 + other | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WINSTON III, EDWARD B | 1 | 20.0% | +31.3% |
| SWITZER, JULIET CAROLINE | 1 | 42.4% | +54.0% |
| PLAYER, ROBERT AUSTIN | 1 | 13.6% | +34.1% |
| FRUMKIN, JESSE P | 1 | 69.9% | +47.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18511862 | OMICS-INFERRED BODY INDEX METHOD AND SYSTEM | WINSTON III, EDWARD B | — |
| 18284033 | COMPOSITIONS AND METHODS FOR DETECTING, PREVENTING, AND TREATING DISTURBED MICROBIOTA-IMMUNE HOMEOSTASIS | SWITZER, JULIET CAROLINE | — |
| 18168056 | DETERMINING VIABILITY AND TREATMENT OF DISEASE AGENTS | PLAYER, ROBERT AUSTIN | — |
| 18160678 | PREDICTING A RECOMMENDED THERAPY FROM GUT COMPOSITIONAL DATA | FRUMKIN, JESSE P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18511862 | OMICS-INFERRED BODY INDEX METHOD AND SYSTEM | WINSTON III, EDWARD B | — |
| 18284033 | COMPOSITIONS AND METHODS FOR DETECTING, PREVENTING, AND TREATING DISTURBED MICROBIOTA-IMMUNE HOMEOSTASIS | SWITZER, JULIET CAROLINE | — |
| 18168056 | DETERMINING VIABILITY AND TREATMENT OF DISEASE AGENTS | PLAYER, ROBERT AUSTIN | — |
| 18160678 | PREDICTING A RECOMMENDED THERAPY FROM GUT COMPOSITIONAL DATA | FRUMKIN, JESSE P | — |
| Art Unit | Apps |
|---|---|
| 3683 | 1 |
| 1682 | 1 |
| 1686 | 1 |
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18511862 | OMICS-INFERRED BODY INDEX METHOD AND SYSTEM | WINSTON III, EDWARD B | 3683 | §101 | Non-Final OA | — | Pending | Nov 16, 2023 |
| 18284033 | COMPOSITIONS AND METHODS FOR DETECTING, PREVENTING, AND TREATING DISTURBED MICROBIOTA-IMMUNE HOMEOSTASIS | SWITZER, JULIET CAROLINE | 1682 | §101§103§112 | Final Rejection | — | Pending | Sep 25, 2023 |
| 18168056 | DETERMINING VIABILITY AND TREATMENT OF DISEASE AGENTS | PLAYER, ROBERT AUSTIN | 1686 | §101§103§112 | Non-Final OA | — | Pending | Feb 13, 2023 |
| 18160678 | PREDICTING A RECOMMENDED THERAPY FROM GUT COMPOSITIONAL DATA | FRUMKIN, JESSE P | 1685 | §101§102 | Non-Final OA | — | Pending | Jan 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInstitute for Systems Biology has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Edward B Winston III has the most, with 1 of Institute for Systems Biology's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
